Menumenu
  • slide

    Current practice insights into the use of biologicals

  • slide

    Rapid access to our in-house patient-centric Database Network

  • slide

    An experienced sparring partner for your European healthcare questions

  • slide

    Dedicated to research real-life health care for the benefit of patients

  • News

    Find our latest newsletter online

    In the current issue: Medication for disorders of the central nervous system, RWE for market access and HEOR and our recent publications PHARMO's latest newsletter is published online, click here to read it. Subscribe to our newsletter to r...

    Anticoagulant treatment after VTE in the Netherlands: A retrospective cohort study

    Treatment after venous thromboembolism (VTE) as captured in observational healthcare data generally follows the Dutch guidelines, except for the duration of low-molecular-weight heparin treatment, which was longer than recommended. This was concluded...

    The effect of switching from Thyrax Duotab to other brands of levothyroxine
    First results and interim advice

    First results and interim advice The stock-out of Thyrax Duotab in the Netherlands forced thousands of Thyrax Duotab users to switch to other brands of levothyroxine. The Dutch Society for Endocrinology (NVE) and the Dutch Thyroid Organisation (S...

  • Events

    Insight into the use and indication of drugs: a pilot study in patients with colon or rectal cancer
    Presentation at the Dutch Hospital Pharmacy days 2016

    Josine Kuiper, our oncology expert researcher, presented the first results of the Rx-pilot that provides insight into the use and outcomes of medicines in hospitals. Her presentation was held at the Dutch hospital pharmacy conference 2016. The pilot ...

    PHARMO at ISPOR Vienna!

    The PHARMO team had a great time at ISPOR Vienna! It was a pleasure to meet all the experts in the field, (re)connect with our clients and exchange ideas about the PHARMO Database Network and our expertise in outcomes and effectiveness research in Eu...

    PHARMO won ‘Best in stream’ award at PhUSE Annual Conference, Barcelona 9th-12th October 2016

    Edith Heintjes won the ‘Best in stream’ award with her presentation ‘Real-world evidence: a comparison between countries: common data models and SAS catalogs’ in the RWE stream at this year’s Pharmaceutical Users Software Exchange meeting. ...

  • Vacancy

    No vacancies

    True to our mission to excel in the interests of improving patient treatment and care, we operate in an entrepreneurial and multidisciplinary environment. The specialists we recruit are from various backgrounds, including: epidemiologists, pharmacist...

  • icon

    What we do

    As an independent research organisation dedicated to the study of epidemiology, drug utilisation, drug safety, health outcomes, and utilisation of healthcare resources PHARMO assists its clients in their decision-making.

  • icon

    What we have

    PHARMO Database Network: we have rapid access to our rich population-based network of databases. Data are derived from different primary and secondary healthcare settings. For our observational studies disease-specific cohorts are created from the various databases.

Publications

  • Asthma related medication use and exacerbations in children and adolescents with type 1 diabetes

    Read more
  • Drug dispensings among elderly in the year before colon cancer diagnosis versus matched cancer-free controls

    Read more
  • Characterization and cholesterol management in patients with cardiovascular events and/or type 2 diabetes in the Netherlands

    Read more
  • Cardiovascular medication use and cardiovascular disease in children and adolescents with type 1 diabetes: a population-based cohort study

    Read more